Basic Information
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in innovative drug research, primarily focusing on Alzheimer's disease. The company is listed on the Nasdaq First North Premier Growth Market and is developing five drug candidates based on two research platforms, NeuroRestore and Alzstatin.
AlzeCure Pharma AB
Stockholm,Stockholm,Sweden
less than 15 people
January 01, 2012
info@alzecurepharma.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios